Incyte's experimental skin disease drug met the main goal of two separate late-stage trials, the company said on Monday, but its shares declined 11% as the drug significantly underperformed prior ...

Stock market sell-offs are often great opportunities to buy dividend stocks. One of the easiest ways to capitalize on this ...

AbbVie (NYSE:ABBV) has recently seen promising developments with the release of favorable final results from the MIRASOL ...

Some healthcare stocks are better picks than others. And you won't need a fortune to invest in a few of the best. Here are three no-brainer healthcare stocks to buy with $1,000 right now. Where to ...

AbbVie Inc. stands out as one of the top pharma stocks to buy, according to hedge funds. The company exceeded analyst ...

Researchers in Gastroenterology evaluated strategies for preventing avoidable colorectal cancers after colonoscopy. In ...

Pharma brands achieved the most impressions from ABC and saw a year-over-year increase in impressions from cable channels like Fox News, CNN and MSNBC.

The third-place slot marked another return to form. Novo Nordisk’s Wegovy reclaimed the seat it held in December, backed by ...

AbbVie (NYSE:ABBV) is navigating significant shareholder activism as it urges opposition to two governance proposals ahead of ...

While Humira’s 2023 loss of exclusivity hung over AbbVie’s head for years, the ascent of the Chicago drugmaker’s immunology successors Skyrizi and Rinvoq under prior CEO Richard Gonzalez has swiftl | ...

Investing some of your tax refund in stocks can help build your portfolio. The three stocks below trade at forward earnings ...

AbbVie has expanded the availability of SKYRIZI in Canada for ulcerative colitis, strengthening its presence in the ...